HC Wainwright & Co. reiterates Buy rating on Cardiol Therapeutics, $9 price target

HC Wainwright & Co. reiterated their Buy rating on Cardiol Therapeutics's stock with a price target of $9.00.The price target implies an upside of 237.1% from the Sep 22 close of $2.67.Key takeaways from the analyst notePositive Trial Results: Cardiol Therapeutics received a Buy rating due to the l…